Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Jazz sells $500mm of its 1.50% senior notes

Executive Summary

Jazz Pharmaceuticals PLC (neurology and hematology/oncology therapies) sold $500mm of its 1.50% senior notes to qualified institutional investors. The notes mature on August 15, 2024 and convert to common at a rate of 4.5659 shares per $1k principal amount, or $219.02 per share. (The market average was $147.77 at the time of the transaction.) Proceeds will be used to repay existing debt and support general business activities.
Deal Industry
  • Pharmaceuticals
    • Drug Delivery
      • Nasal
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement
    • Nonconvertible Debt

Related Companies